Wells Fargo’s Horizon Kinetics Medical ETF MEDX Stock Holding History

Wells Fargo’s Portfolio MEDX Stock Details MEDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$29	Buy	+1	New	+$34	﹤0.01%	6713
2025 Q4	–	Sell	-1	Closed	-$32	–	6892
2025 Q3	$23	Hold	1	–	–	﹤0.01%	6665
2025 Q2	$20	Buy	+1	New	+$26	﹤0.01%	6788
2025 Q1	–	Sell	-2,142	Closed	-$59.2K	–	6796
2024 Q4	$56K	Hold	2,142	–	–	﹤0.01%	5447
2024 Q3	$65.5K	Buy	+2,142	New	+$66.1K	﹤0.01%	5245

Other funds holding MEDX

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HWM

HighMark Wealth Management St. Paul, Minnesota $246M AUM 35.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wells Fargo's MEDX Position: Q1 2026 in Review

Wells Fargo opened a new position in Horizon Kinetics Medical ETF (MEDX) in Q1 2026: 1 share worth $29. The stake represents ﹤0.01% of the portfolio and ranks #6713 among its holdings. This is a return to the name: Wells Fargo previously reported a position in MEDX as recently as Q3 2025.

Wells Fargo first reported a position in MEDX in Q3 2024 and has held it in 5 quarters since. The position peaked at $65.5K in Q3 2024. 6 funds tracked by Wall St. Rank hold MEDX as of Q1 2026.

Wells Fargo held 1 share of Horizon Kinetics Medical ETF worth $29 as of Q1 2026.
Horizon Kinetics Medical ETF was a new Wells Fargo position in Q1 2026.
Horizon Kinetics Medical ETF made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6713 holding.
Wells Fargo first reported a position in Horizon Kinetics Medical ETF in Q3 2024 and has held it in 5 quarters since.
Wells Fargo's Horizon Kinetics Medical ETF position peaked at $65.5K in Q3 2024.
6 funds tracked by Wall St. Rank held Horizon Kinetics Medical ETF as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.